• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

    2.285 -0.045 (-1.93%)
    Streaming Delayed Price Updated: 9:46 AM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 31,588
    Open 2.360
    Bid (Size) 2.270 (2)
    Ask (Size) 2.300 (4)
    Prev. Close 2.330
    Today's Range 2.260 - 2.369
    52wk Range 2.215 - 26.05
    Shares Outstanding 736,213
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders To Inquire About Securities Fraud Class Action
    From Glancy Prongay & Murray LLP
    Via Business Wire

    Performance

    YTD
    -89.2%
    -89.2%
    1 Month
    -21.7%
    -21.7%
    3 Month
    -59.8%
    -59.8%
    6 Month
    -52.8%
    -52.8%
    1 Year
    -87.5%
    -87.5%

    More News

    Read More
    Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR
    From Pomerantz LLP
    Via GlobeNewswire
    Law Offices of Howard G. Smith Encourages Jasper Therapeutics, Inc. (JSPR) Investors To Inquire About Securities Fraud Class Action
    From Law Offices of Howard G. Smith
    Via Business Wire
    Law Offices of Frank R. Cruz Encourages Jasper Therapeutics, Inc. (JSPR) Investors To Inquire About Securities Fraud Class Action
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    JASPER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Jasper Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Securities Fraud Investigation Into Jasper Therapeutics, Inc. (JSPR) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Jasper Therapeutics, Inc. (JSPR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
    From DJS Law Group
    Via Business Wire
    Securities Fraud Investigation Into Jasper Therapeutics, Inc. (JSPR) Announced – Investors Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    JSPR Stockholder Alert: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against Jasper Therapeutics, Inc.
    From Robbins LLP
    Via GlobeNewswire
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
    From Faruqi & Faruqi, LLP
    Via Business Wire
    JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Stay updated with the stocks that are on the move in today's after-hours session.
    Via Chartmill
    Jasper Reports Wider Loss in Fiscal Q2
    Via The Motley Fool
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Jasper Therapeutics, Inc. - Class A Common Stock publicly traded?
    Yes, Jasper Therapeutics, Inc. - Class A Common Stock is publicly traded.
    What exchange does Jasper Therapeutics, Inc. - Class A Common Stock trade on?
    Jasper Therapeutics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock?
    The ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock is JSPR on the Nasdaq Stock Market
    What is the current price of Jasper Therapeutics, Inc. - Class A Common Stock?
    The current price of Jasper Therapeutics, Inc. - Class A Common Stock is 2.285
    When was Jasper Therapeutics, Inc. - Class A Common Stock last traded?
    The last trade of Jasper Therapeutics, Inc. - Class A Common Stock was at 09/26/25 09:46 AM ET
    What is the market capitalization of Jasper Therapeutics, Inc. - Class A Common Stock?
    The market capitalization of Jasper Therapeutics, Inc. - Class A Common Stock is 1.68M
    How many shares of Jasper Therapeutics, Inc. - Class A Common Stock are outstanding?
    Jasper Therapeutics, Inc. - Class A Common Stock has 2M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.